Cramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects
May 10, 2018 at 18:31 PM EDT
Jim Cramer examines "the four horsemen of biotech" to see if their weakening stocks can regain momentum.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|